Cargando…

Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels

BACKGROUND: Neurodegeneration with brain iron accumulation (NBIA) disorders are a group of neurodegenerative diseases that have in common the accumulation of iron in the basal nuclei of the brain which are essential components of the extrapyramidal system. Frequent symptoms are progressive spasticit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talaverón-Rey, Marta, Álvarez-Córdoba, Mónica, Villalón-García, Irene, Povea-Cabello, Suleva, Suárez-Rivero, Juan M., Gómez-Fernández, David, Romero-González, Ana, Suárez-Carrillo, Alejandra, Munuera-Cabeza, Manuel, Cilleros-Holgado, Paula, Reche-López, Diana, Piñero-Pérez, Rocío, Sánchez-Alcázar, José A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091671/ https://www.ncbi.nlm.nih.gov/pubmed/37046296 http://dx.doi.org/10.1186/s13023-023-02687-5

Ejemplares similares

Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2022)

Pantothenate and L-Carnitine Supplementation Improves Pathological Alterations in Cellular Models of KAT6A Syndrome
por: Munuera-Cabeza, Manuel, et al.
Publicado: (2022)

Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2021)

Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration
por: Villalón-García, Irene, et al.
Publicado: (2022)

Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2023)

Precision medicine in pantothenate kinase-associated neurodegeneration
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2019)

Neurodegeneration, Mitochondria, and Antibiotics
por: Suárez-Rivero, Juan M., et al.
Publicado: (2023)

UPR(mt) activation improves pathological alterations in cellular models of mitochondrial diseases
por: Suárez-Rivero, Juan M., et al.
Publicado: (2022)

Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?
por: Suárez-Rivero, Juan M., et al.
Publicado: (2022)

Precision Medicine in Rare Diseases
por: Villalón-García, Irene, et al.
Publicado: (2020)

mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases
por: Cilleros-Holgado, Paula, et al.
Publicado: (2023)

Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients’ Brain in a Dish
por: Povea-Cabello, Suleva, et al.
Publicado: (2021)

Coenzyme Q(10): Novel Formulations and Medical Trends
por: Pastor-Maldonado, Carmen J., et al.
Publicado: (2020)

Coenzyme Q(10) Analogues: Benefits and Challenges for Therapeutics
por: Suárez-Rivero, Juan M., et al.
Publicado: (2021)

From Mitochondria to Atherosclerosis: The Inflammation Path
por: Suárez-Rivero, Juan M., et al.
Publicado: (2021)

Mitochondria and Antibiotics: For Good or for Evil?
por: Suárez-Rivero, Juan M., et al.
Publicado: (2021)

Pterostilbene in Combination With Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial Diseases
por: Suárez-Rivero, Juan M., et al.
Publicado: (2022)

Atherosclerosis and Coenzyme Q(10)
por: Suárez-Rivero, Juan M., et al.
Publicado: (2019)

Novel PANK2 Mutations in Patients With Pantothenate Kinase-Associated Neurodegeneration and the Genotype–Phenotype Correlation
por: Li, Wen-Bin, et al.
Publicado: (2022)

A Novel Nonsense Mutation in PANK2 Gene in Two Patients with Pantothenate Kinase-Associated Neurodegeneration
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2016)

Novel PANK2 mutation in the first Greek compound heterozygote patient with pantothenate-kinase-associated neurodegeneration
por: Paraskevas, George P, et al.
Publicado: (2017)

A novel homozygous variation in the PANK2 gene in two Persian siblings with atypical pantothenate kinase associated neurodegeneration
por: Habibi, Amir Hasan, et al.
Publicado: (2019)

A Novel PANK2 Mutation in a Patient with Atypical Pantothenate-Kinase-Associated Neurodegeneration Presenting with Adult-Onset Parkinsonism
por: Seo, Joo-Hyun, et al.
Publicado: (2009)

Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model
por: Brunetti, Dario, et al.
Publicado: (2012)

A variation in PANK2 gene is causing Pantothenate kinase-associated Neurodegeneration in a family from Jammu and Kashmir – India
por: Angural, Arshia, et al.
Publicado: (2017)

Typical pantothenate kinase-associated neurodegeneration caused by compound heterozygous mutations in PANK2 gene in a Chinese patient: a case report and literature review
por: Tao, Yilun, et al.
Publicado: (2023)

Basal ganglia calcification and novel compound heterozygous mutations in the PANK2 gene in a Chinese boy with classic Pantothenate kinase-associated neurodegeneration: A case report
por: Shi, Xulai, et al.
Publicado: (2018)

Pantothenate kinase-associated neurodegeneration
por: Hundallah, Khalid, et al.
Publicado: (2017)

PKAN neurodegeneration and residual PANK2 activities in patient erythrocytes
por: Werning, Maike, et al.
Publicado: (2020)

Dynamic Reorganization of the Cytoskeleton during Apoptosis: The Two Coffins Hypothesis
por: Povea-Cabello, Suleva, et al.
Publicado: (2017)

Novel PANK2 mutation in a Chinese boy with PANK2-associated neurodegeneration: A case report and review of Chinese cases
por: Zhang, Yingying, et al.
Publicado: (2019)

Pantothenate kinase-associated neurodegeneration is not a synucleinopathy
por: Li, A, et al.
Publicado: (2013)

Proposed Therapies for Pantothenate-Kinase-Associated Neurodegeneration
por: Jackowski, Suzanne
Publicado: (2019)

Redesigning therapies for pantothenate kinase–associated neurodegeneration
por: Munshi, Muhammad I., et al.
Publicado: (2022)

Coenzyme A corrects pathological defects in human neurons of PANK2‐associated neurodegeneration
por: Orellana, Daniel I, et al.
Publicado: (2016)

Late Onset Atypical Pantothenate-Kinase-Associated Neurodegeneration
por: Diaz, Natalie
Publicado: (2013)

Deep Brain Stimulation for Pantothenate Kinase-Associated Neurodegeneration
por: Garcia-Ruiz, Pedro J., et al.
Publicado: (2015)

A therapeutic approach to pantothenate kinase associated neurodegeneration
por: Sharma, Lalit Kumar, et al.
Publicado: (2018)

Eye of the Tiger Sign in Pantothenate Kinase-Associated Neurodegeneration
por: Choayb, S., et al.
Publicado: (2021)

Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
por: Yang, Dahae, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fm571jls7ohb8e3jke0o2srouc